A Twin Study of Erectile Dysfunction

Archives of Internal Medicine

Volumn 164, Issue 2, 2004, Pages 165-168

  Fischer, Mary E ^a   Vitek, Mary Ellen ^b   Hedeker, Don ^c   Henderson, William G ^b   Jacobsen, Steven J ^d   Goldberg, Jack ^a  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b HINES VA HOSPITAL   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIZYGOTIC TWINS; ERECTILE DYSFUNCTION; GENETIC POLYMORPHISM; HEALTH SURVEY; HEREDITY; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; MONOZYGOTIC TWINS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TWINS;

ADULT; AGE FACTORS; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; MILITARY PERSONNEL; PREVALENCE; QUESTIONNAIRES; REGISTRIES; RISK FACTORS; TWINS; UNITED STATES;

EID: 0942287305     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.2.165     Document Type: Article

References (38)

1. National Institutes of Health Consensus Development Panel on Impotence. Impotence. JAMA. 1993;270:83-90.
2. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54-61.
3. Laumann ED, Paik A, Rosen RC. Sexual dysfunction in the United States, prevalence and predictors. JAMA. 1999;281:537-544.
4. Johannes CB, Araujo AB, Feldman FA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study. J Urol. 2000;163:460-463.
5. Parazzini F, Menchini FF, Bortolotti A, et al. Frequency and determinants of erectile dysfunction in Italy. Eur Urol. 2000;87:48-49.
6. Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tajad I, Rodriguez-Vela L, Jimenez-Cruz JF, Burgos-Rodriguez R. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol. 2001;166:569-575.
7. Duarte Moreira E Jr, Najjar Abdo CH, Barreto Torres E, Lisboa Lobo CF, Saraiva Fittpaldi JA. Prevalence and correlates of erectile dysfunction: results of the Brazilian Study of Sexual Behavior. Urology. 2001;58:583-588.
8. Green JS, Holden ST, Ingram P, Bose P, St George DP, Bowsher WG. An investigation of erectile dysfunction in Gwent, Wales. BJU Int. 2001;88:551-553.
9. Grimm RH Jr, Grandits G, Svendsen K. Sexual problems and antihypertensive drug treatment: results of the Treatment of Mild Hypertension Study (TOMHS) [abstract 634]. J Urol. 1996;155:469A.
10. Derby CA, Barbour MM, Hume AL, McKinlay JB. Drug therapy and prevalence of erectile dysfunction in the Massachusetts Male Aging Study cohort. Pharmacotherapy. 2001;21:676-683.
11. Klein R, Klein BEK, Lee KE, Moss S, Cruickshanks KJ. Prevalence of self-reported erectile dysfunction in people with long-term IDDM. Diabetes Care. 1996;19:135-141.
12. Mannino DM, Klevens RM, Flanders WD. Cigarette smoking: an independent risk factor for impotence? Am J Epidemiol. 1994;140:1003-1008.
13. Feldman HA, Johannes CB, Derby CA, et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts Male Aging Study. Prev Med. 2000;30:328-338.
14. McVary KT, Carrier S, Wessells H, Subcommittee on Smoking and Erectile Dysfunction Socioeconomic Committee, Sexual Medicine Society of North America. Smoking and erectile dysfunction: evidence based analysis. J Urol. 2001;166:1624-1632.
15. Schachter M. Erectile dysfunction and lipid disorders. Curr Med Res Opin. 2000;16(suppl 1):S9-S12.
16. Sullivan ME, Miller MA, Bell CR, et al. Fibrinogen, lipoprotein (a) and lipids in patients with erectile dysfunction: a preliminary study. Int Angiol. 2001;20:195-199.
17. Aytac IA, Araujo AB, Johannes CB, Kleinman KP, McKinlay JB. Socioeconomic factors and incidence of erectile dysfunction: findings of the longitudinal Massachusetts Male Aging Study. Soc Sci Med. 2000;51:771-778.
18. Eisen S, True W, Goldberg J, Henderson W, Robinette CD. The Vietnam Era Twin (VET) Registry: method of construction. Acta Genet Med Gemellol (Roma). 1987;36:61-66.
19. Goldberg J, Henderson WG, Eisen SA, et al. A strategy for assembling samples of adult twin pairs in the United States. Stat Med. 1993;12:1693-1702.
20. Eisen S, Neuman R, Goldberg J, Rice J, True W. Determining zygosity in the Vietnam Era Twin Registry: an approach using questionnaires. Clin Genet. 1989;35:423-432.
21. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822-830.
22. Hedeker D, Gibbons RD. A random-effects ordinal regression model for multilevel analysis. Biometrics. 1994;50:933-944.
23. Guo G, Wang J. The mixed or multilevel model for behavior genetic analysis. Behav Genet. 2002;32:37-49.
24. Hedeker D, Gibbons RD. MIXOR: a computer program for mixed-effects ordinal regression analyses. Comput Methods Programs Biomed. 1996;49:157-176.
25. Burnett AL, Lowenstein CJ, Bredt DS, Chang TS, Snyder SH. Nitric oxide: a physiologic mediator of penile erection. Science. 1992;257:401-403.
26. Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med. 1992;326:90-94.
27. Becker AJ, Uckert S, Stief CF, et al. Possible role of bradykinin and angiotensin II in the regulation of penile erection and detumescence. Urology. 2001;57:193-198.
28. Kuthe A, Magert H, Uckert S, Forssmann WG, Stief CG, Jonas U. Gene expression of the phosphodiesterases 3A and 5A in human corpus cavernosum penis. Eur Urol, 2000;38:108-114.
29. Kuthe A, Wiedenroth A, Magert HJ, et al. Expression of different phosphodiesterase genes in human cavernous smooth muscle. J Urol. 2001;165:280-283.
30. Bivalacqua TJ, Hellstrom WJ, Kadowitz Champion HC. Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochem Biophys Res Commun. 2001;283:923-927.
31. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the "Cologne Male Survey." Int J Impot Res. 2000;12:305-311.
32. Ansong KS, Lewis C, Jenkins P, Bell J. Epidemiology of erectile dysfunction: a community-based study in rural New York State. Ann Epidemiol. 2000;10:293-296.
33. Blanker MH, Bosch JL, Groeneveld FP, et al. Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: prevalence, concern, and relation to sexual activity. Urology. 2001;57:763-768.
34. Anderson BL, Broffit B. Is there a reliable and valid self-report measure of sexual function? Arch Sex Behav. 1988;17:509-525.
35. Rosen RC. Sexual function assessment in the male: physiological and self-report measures. Int J Impot Res. 1998;10:S59-S63.
36. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology. 1999;54:346-351.
37. Cappelleri JC, Siegel RL, Osterloh IH, Rosen RC. Relationship between patient self-assessment of erectile function and the erectile function domain of the International Index of Erectile Function. Urology. 2000;56:477-481.
38. Blanker MH, Bohnen AM, Groeneveld FPMJ, et al. Correlates for erectile and ejaculatory dysfunction in older Dutch men: a community-based study. J Am Geriatr Soc. 2001;49:436-442.